世界のマイクロバイオームシーケンス市場

本レポートは、マイクロバイオームシーケンシング市場をコンポーネント、シーケンシング技術、研究室の種類、アプリケーション、エンドユーザー別に分析し、主要なトレンドと成長要因に関する洞察を提供しています。また、主要企業とその製品・サービスについても分析しています。本調査の基準年は2023年、予測年は2024年で、2029年までの予測と、予測期間の年平均成長率（CAGR）を記載しています。

Report Highlights

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

世界のマイクロバイオームシーケンシング市場は、2024年の15億ドルから2024年から2029年の予測期間中に19.3%の複合年間成長率（CAGR）で成長し、2029年末までに37億ドルに達すると予測されています。

Summary:

The global market for microbiome sequencing was worth $1.3 billion in 2023 and is expected to grow at a CAGR of 19.3% during the forecast period to reach $3.7 billion by the end of 2029. The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user. Next-generation sequencing (NGS) technologies have transformed the discipline by providing high-throughput, affordable analysis of microbial communities with the ability to sequence millions of DNA fragments at once. By combining microbiome data with genomics, proteomics and metabolomics, researchers have gained a full understanding of microbial functions in health and

disease. In addition, the creation of smaller, less expensive sequencing instruments, such as Illumina’s MiSeq i100 line, has placed sequencing technologies within reach of smaller research and clinical labs. Organizations are making significant investments in R&D to create affordable sequencing platforms, bioinformatics software and data analysis solutions enabled by AI to enhance precision and efficiency. Strategic partnerships and grants also enhance research in microbiomes, leading to the development of new applications in precision medicine and microbiome therapeutics.

Report Scope

The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user, offering insights into key trends and growth drivers. The study concludes with an analysis of leading companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period.

This report analyzes the macroeconomic factors affecting the market. Market drivers, restraints and opportunities are identified. The report covers the regulatory landscape, recent technologies and patents in the market, as well as innovations in products and performance. The report also covers the competitive landscape, ESG factors and profiles of leading companies.

Regional analysis covers North America (U.S., Canada and Mexico), Europe (U.K., Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Middle East and Africa (MEA) and South America (Brazil, Argentina and Rest of South America).

Report Synopsis

Report Includes

– 50 data tables and 51 additional tables

– Analyses of the global market trends for microbiome sequencing technologies, with revenue data from 2021-2024, and projected CAGRs through 2029

– Estimates of the size and revenue prospects for the global market, along with a market share analysis by sequencing technology, component, laboratory type, application, end user and region

– Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors

– Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses

– A look at the emerging trends and opportunities in microbiome-based therapeutics, clinical trials

– Evaluation of recent patent activity and key granted and published patents

– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

– Profiles of leading companies including Illumina Inc., Qiagen, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Plc., and PacBio.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

Outlook

Macroeconomic Analysis

Impact of U.S.-China Trade War

Chapter 3 Market Dynamics

Market Drivers

Decreasing Cost per Genome

Government Initiatives and Funding

Advances in Sequencing Technology

Market Restraints

Data Complexity and Bioinformatics Challenges

Lack of Standardized Protocols and Reference Databases

Lack of Grant Funding

Market Opportunities

Personalized Medicine and Diagnostics

Drug Discovery and Development

Agriculture and the Food Industry

Chapter 4 Regulatory Landscape

Overview

Chapter 5 Emerging Technologies and Patent Analysis

Emerging Technologies

Nanopore Sequencing

SMRT Sequencing

FACS with Microfluidics

Metatranscriptome Sequencing

Patent Analysis

Regional Patterns

Chapter 6 Market Segment Analysis

Market Trends

Segmentation Breakdown

Microbiome Sequencing: Global Markets

Market Analysis by Sequencing Technology

High-throughput Sequencing

Sanger Sequencing

Third-Generation Sequencing

Market Analysis by Component

Reagents and Kits

Instruments

Market Analysis by Laboratory Type

Wet Labs

Dry Labs

Market Analysis by Application

Disease Diagnosis Research

Personalized Medicine

Drug Discovery

Genetic Screening

Other Applications

Market Analysis by End User

Pharmaceutical and Biotechnology

Academic Centers and Research Institutes

Other End Users

Geographic Breakdown

Market Breakdown by Region

North America

Europe

Asia-Pacific

MEA

South America

Chapter 7 Competitive Landscape

Key Suppliers and Manufacturers

Ranking of Companies in the Microbiome Sequencing Industry

Strategic Analysis

Chapter 8 Environmental, Social, and Governance (ESG) Perspective

Sustainability in the Microbiome Sequencing Market

ESG Risks and Ratings: Understanding the Data

BCC Research Viewpoint

Chapter 9 Appendix

Research Methodology

Sources

Abbreviations

Company Profiles

BASECLEAR BV

CD GENOMICS

CHARLES RIVER LABORATORIES

COSMOSID

CROWN BIOSCIENCE

DANAHER CORP.

EUROFINS SCIENTIFIC

ILLUMINA INC.

MERIEUX NUTRISCIENCES

MICROBIOME INSIGHTS

NOVOGENE CO. LTD.

OXFORD NANOPORE TECHNOLOGIES PLC

PACBIO

QIAGEN

THERMO FISHER SCIENTIFIC INC.

Emerging Startups

Pendulum

Microba

Biomesense

List of Tables

Summary Table : Global Market for Microbiome Sequencing, by Region, Through 2029

Table 1 : Cost Per Genome, 2019–2022

Table 2 : FDA-Approved Personalized Medicines, 2015–2022

Table 3 : Regulatory Scenario for Microbiome Sequencing, by Country

Table 4 : Global Market for Microbiome Sequencing, Through 2029

Table 5 : Global Market for Microbiome Sequencing, by Sequencing Technology, Through 2029

Table 6 : NGS Technologies

Table 7 : Experimental HTS Technology

Table 8 : Illumina’s Two-Channel SBS Instruments

Table 9 : Comparison of Sanger Sequencing and Targeted NGS

Table 10 : Global Market for Microbiome Sequencing, by Component, Through 2029

Table 11 : Pricing of Microbiome Products, by Company

Table 12 : Global Market for Microbiome Sequencing, by Laboratory Type, Through 2029

Table 13 : Global Market for Microbiome Sequencing, by Application, Through 2029

Table 14 : Global Market for Microbiome Sequencing Market, by End User, Through 2029

Table 15 : Partnerships between Biotech and Pharma Companies for Microbiome Projects

Table 16 : Academic Centers and Research Institutes Engaged in Microbiome Research

Table 17 : Global Market for Microbiome Sequencing, by Region, Through 2029

Table 18 : North American Market for Microbiome Sequencing, by Country, Through 2029

Table 19 : North American Market for Microbiome Sequencing, by Sequencing Technology, Through 2029

Table 20 : North American Market for Microbiome Sequencing, by Component, Through 2029

Table 21 : North American Market for Microbiome Sequencing, by Laboratory Type, Through 2029

Table 22 : North American Market for Microbiome Sequencing, by Application, Through 2029

Table 23 : North American Market for Microbiome Sequencing, by End User, Through 2029

Table 24 : European Market for Microbiome Sequencing, by Country, Through 2029

Table 25 : European Market for Microbiome Sequencing, by Sequencing Technology, Through 2029

Table 26 : European Market for Microbiome Sequencing, by Component, Through 2029

Table 27 : European Market for Microbiome Sequencing, by Laboratory Type, Through 2029

Table 28 : European Market for Microbiome Sequencing, by Application, Through 2029

Table 29 : European Market for Microbiome Sequencing, by End User, Through 2029

Table 30 : Asia-Pacific Market for Microbiome Sequencing, by Country, Through 2029

Table 31 : Asia-Pacific Market for Microbiome Sequencing, by Sequencing Technology, Through 2029

Table 32 : Asia-Pacific Market for Microbiome Sequencing, by Component, Through 2029

Table 33 : Asia-Pacific Market for Microbiome Sequencing, by Laboratory Type, Through 2029

Table 34 : Asia-Pacific Market for Microbiome Sequencing, by Application, Through 2029

Table 35 : Asia-Pacific Market for Microbiome Sequencing, by End User, Through 2029

Table 36 : MEA Market for Microbiome Sequencing, by Region, Through 2029

Table 37 : MEA Market for Microbiome Sequencing, by Sequencing Technology, Through 2029

Table 38 : MEA Market for Microbiome Sequencing, by Component, Through 2029

Table 39 : MEA Market for Microbiome Sequencing, by Laboratory Type, Through 2029

Table 40 : MEA Market for Microbiome Sequencing, by Application, Through 2029

Table 41 : MEA Market for Microbiome Sequencing, by End User, Through 2029

Table 42 : South American Market for Microbiome Sequencing, by Country, Through 2029

Table 43 : South American Market for Microbiome Sequencing, by Sequencing Technology, Through 2029

Table 44 : South American Market for Microbiome Sequencing, by Component, Through 2029

Table 45 : South American Market for Microbiome Sequencing, by Laboratory Type, Through 2029

Table 46 : South American Market for Microbiome Sequencing, by Application, Through 2029

Table 47 : South American Market for Microbiome Sequencing, by End User, Through 2029

Table 48 : Ranking of Leading Companies in the Microbiome Sequencing Industry, 2023

Table 49 : Strategic Analysis in the Microbiome Sequencing Industry

Table 50 : ESG Rankings for Major Microbiome Sequencing Companies*

Table 51 : Information Sources for This Report

Table 52 : Abbreviations Used in the Report

Table 53 : BaseClear BV: Company Snapshot

Table 54 : BaseClear BV: Product Portfolio

Table 55 : CD Genomics: Company Snapshot

Table 56 : CD Genomics: Product Portfolio

Table 57 : Charles River Laboratories: Company Snapshot

Table 58 : Charles River Laboratories: Financial Performance, FY 2023 and 2024

Table 59 : Charles River Laboratories: Product Portfolio

Table 60 : Charles River Laboratories: News/Key Developments, 2023

Table 61 : CosmosID: Company Snapshot

Table 62 : CosmosID: Product Portfolio

Table 63 : CosmosID: News/Key Developments, 2022

Table 64 : Crown Bioscience: Company Snapshot

Table 65 : Crown Bioscience: Product Portfolio

Table 66 : Danaher Corp.: Company Snapshot

Table 67 : Danaher Corp.: Financial Performance, FY 2023 and 2024

Table 68 : Danaher Corp.: Product Portfolio

Table 69 : Danaher Corp.: News/Key Developments, 2024

Table 70 : Eurofins Scientific: Company Snapshot

Table 71 : Eurofins Scientific: Financial Performance, FY 2022 and 2023

Table 72 : Eurofins Scientific: Product Portfolio

Table 73 : Illumina Inc.: Company Snapshot

Table 74 : Illumina Inc.: Financial Performance, FY 2023 and 2024

Table 75 : Illumina Inc.: Product Portfolio

Table 76 : Illumina Inc.: News/Key Developments, 2022-2025

Table 77 : Merieux NutriSciences: Company Snapshot

Table 78 : Merieux NutriSciences: Product Portfolio

Table 79 : Microbiome Insights: Company Snapshot

Table 80 : Microbiome Insights: Product Portfolio

Table 81 : Microbiome Insights: News/Key Developments, 2024

Table 82 : Novogene Co. Ltd.: Company Snapshot

Table 83 : Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024

Table 84 : Novogene Co. Ltd.: Product Portfolio

Table 85 : Oxford Nanopore Technologies plc: Company Snapshot

Table 86 : Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024

Table 87 : Oxford Nanopore Technologies plc: Product Portfolio

Table 88 : Oxford Nanopore Technologies plc: News/Key Developments, 2024

Table 89 : PacBio: Company Snapshot

Table 90 : PacBio: Financial Performance, FY 2023 and 2024

Table 91 : PacBio: Product Portfolio

Table 92 : PacBio: News/Key Developments, 2023 and 2024

Table 93 : QIAGEN: Company Snapshot

Table 94 : QIAGEN: Financial Performance, FY 2022 and 2023

Table 95 : QIAGEN: Product Portfolio

Table 96 : QIAGEN: News/Key Developments, 2024

Table 97 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 98 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024

Table 99 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 100 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023

List of Figures

Summary Figure : Global Market Shares of Microbiome Sequencing, by Region, 2023

Figure 1 : Market Dynamics

Figure 2 : Emerging Technologies in Microbiome Sequencing

Figure 3 : Global Market Shares for Microbiome Sequencing, by Sequencing Technology, 2023

Figure 4 : Global Market Shares for Microbiome Sequencing, by Sequencing Technology, 2023

Figure 5 : Global Market Shares for Microbiome Sequencing, by Component, 2023

Figure 6 : Global Market Shares for Microbiome Sequencing, by Laboratory Type, 2023

Figure 7 : Global Market Shares for Microbiome Sequencing, by Application, 2023

Figure 8 : Global Market Shares for Microbiome Sequencing, by End User, 2023

Figure 9 : Global Market Shares for Microbiome Sequencing, by Region, 2023

Figure 10 : North American Market Shares for Microbiome Sequencing, by Country, 2023

Figure 11 : European Market Shares for Microbiome Sequencing, by Country, 2023

Figure 12 : Asia-Pacific Market Shares for Microbiome Sequencing, by Country, 2023

Figure 13 : MEA Market Shares for Microbiome Sequencing, by Region, 2023

Figure 14 : South American Market Shares for Microbiome Sequencing, by Country, 2023

Figure 15 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2024

Figure 16 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2024

Figure 17 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2024

Figure 18 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2024

Figure 19 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023

Figure 20 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023

Figure 21 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024

Figure 22 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024

Figure 23 : Oxford Nanopore Technologies plc: Revenue Shares, by Business Unit, FY 2024

Figure 24 : Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024

Figure 25 : PacBio: Revenue Shares, by Business Unit, FY 2024

Figure 26 : PacBio: Revenue Shares, by Country/Region, FY 2024

Figure 27 : QIAGEN: Revenue Shares, by Business Unit, 2023

Figure 28 : QIAGEN: Revenue Shares, by Country/Region, 2023

Figure 29 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, 2024

Figure 30 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, 2024

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自律型無人潜水機の2030年までの世界市場 2025-06-06
• 世界のSDV(ソフトウェア・デファインド・ビークル)市場 2025-06-06
• 高分子発泡体の世界市場 2025-06-06
• 世界の細胞株と細胞膜市場 2025-06-05
• 世界のエッジAI市場 2025-06-03

BCC Research  出版レポート一覧